![]() |
市場調查報告書
商品編碼
1953432
生物防治市場-全球產業規模、佔有率、趨勢、機會及預測(依產品類型、功能、處理方法、作物類型、地區和競爭格局分類,2021-2031年)Biocontrol Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By Function, By Mode of Treatment, By Crop Type, By Region & Competition, 2021-2031F |
||||||
全球生物防治市場預計將從 2025 年的 42.1 億美元成長到 2031 年的 67.8 億美元,複合年成長率為 8.26%。
該領域專注於利用微生物、大型生物和訊息化合物等天然生物體和物質來防治農業害蟲和植物病害。推動這一領域發展的關鍵因素包括政府加強監管以限制合成化學品的使用,以及全球消費者對無化學殘留食品日益成長的偏好。此外,由於害蟲已對傳統殺蟲劑產生抗藥性,因此迫切需要強力的抗藥性管理策略來應對,這也積極推動了生物藥品的應用。
| 市場概覽 | |
|---|---|
| 預測期 | 2027-2031 |
| 市場規模:2025年 | 42.1億美元 |
| 市場規模:2031年 | 67.8億美元 |
| 複合年成長率:2026-2031年 | 8.26% |
| 成長最快的細分市場 | 宏觀生物學 |
| 最大的市場 | 北美洲 |
儘管呈現上升趨勢,但該行業仍面臨許多挑戰。根據國際生物防治製造商協會的數據,歐洲生物防治市場預計到2024年將達到16億歐元,年成長率接近10%,但複雜且分散的監管環境阻礙了其更廣泛的擴張。各地區冗長且不一致的核准程序常常延緩商業性產品的上市,限制了製造商快速將新產品推向市場以滿足農業需求的能力。
主要作物保護產品生產商的策略性資本配置和產品系列多元化是市場成長的關鍵促進因素。面對日益嚴格的合成農藥監管和市場不穩定,產業領導者正積極轉向生物產品線,以確保穩定的收入來源。這種策略調整正在產生切實的商業效益。例如,科迪華農業科技公司在2025年2月發布的「2024年第四季財務業績」報告中指出,其作物保護劑銷售量年增16%,這主要歸功於拉丁美洲對生物農藥和新型產品的強勁需求。此類企業措施有助於先進配方的快速商業化,有效地將專業研究與大眾市場應用聯繫起來。
綜合蟲害管理(IPM)策略的廣泛應用進一步推動了這一成長。隨著種植者尋求永續的抗藥性管理方法,他們擴大將生物製劑與傳統處理方法結合使用,這一轉變正在改變分銷策略。根據CropLife於2025年3月發布的《生物農藥調查》,86%的受訪農資零售商計劃在即將到來的種植季擴大其生物農藥產品的類型。這種激增的需求正在主要農業地區創造巨大的市場價值。正如《Revista Cultivar》雜誌在2025年11月報道的那樣,2024/25作物年度巴西生物農藥的銷售額達到43.5億雷亞爾,比上一年成長18%。
監管環境的碎片化和複雜性仍然是全球生物防治市場成長的一大障礙。與合成農藥不同,生物製品在許多地區缺乏特定的註冊途徑,迫使生產者遵循繁瑣的化學品核准通訊協定。這種不一致導致數據要求過高,合規成本也隨之增加,給作為行業關鍵創新者的中小企業帶來了沉重負擔。因此,核准流程帶來的經濟負擔和不確定性抑制了對新產品研發的投資,並延緩了永續害蟲防治解決方案的上市。
監管效率低下的影響在比較不同區域市場時特別顯著。根據國際生物防治產品製造商協會(IBMA)2024年的報告,歐洲農民獲得生物防治產品核准的等待時間長達10年,而美國和巴西的競爭對手通常只需兩到三年即可進入市場。這種顯著的差距限制了核准流程緩慢地區有效生物防治產品的供應,從而限制了整體市場潛力,並阻礙了該行業滿足全球對零殘留農業投入品迫切需求的能力。
基於RNA干擾(RNAi)技術的生物農藥的興起,標誌著精準、非基因害蟲防治方案的重大轉變,有效應對了日益嚴重的化學抗藥性問題。與傳統的頻譜農藥不同,這些噴灑型製劑利用雙鏈RNA惰性。這不會改變植物性因組,也不會傷害益蟲,從而避免了基改作物(GMO)所面臨的監管和公眾接受度方面的挑戰。該領域的商業化進程正在加速,生產商正將產品從田間試驗推進到大規模分銷。例如,Greenlight Biosciences公司於2025年3月宣布,已獲得2500萬美元的資金籌措,用於進一步商業化其首款註冊的葉面噴布RNA生物農藥Karantha,該產品專為防治科羅拉多馬鈴薯甲蟲而開發。
同時,生物防治在種子處理應用上的日益普及,正透過以微生物製劑取代新菸鹼類等受監管的合成化學品,改變作物早期保護的方式。這種方法使有益微生物能夠在種子萌發後立即定殖於根際,從而在關鍵的早期生長階段提供針對土壤傳播病原體的系統性防禦,並提高作物對非生物脅迫的耐受性。這種向主要作物的轉變,正在為小眾特色水果和蔬菜以外的市場開闢巨大的潛力。 Evogene公司於2024年11月宣布了其Yaros生物接種劑的商業性擴張計劃,該計劃旨在將其種子處理生物接種劑推廣到美國大豆市場,目標是新增8600萬英畝(約3440萬公頃)此前主要由傳統材料主導的種植面積。
The Global Biocontrol Market is projected to expand from USD 4.21 Billion in 2025 to USD 6.78 Billion by 2031, registering a CAGR of 8.26%. This sector focuses on managing agricultural pests and plant diseases by utilizing natural organisms and substances, such as microbials, macrobials, and semiochemicals. Key factors propelling this growth include increasingly strict government mandates designed to limit synthetic chemical usage and the growing worldwide consumer preference for food free of chemical residues. Additionally, the adoption of these biological agents is being actively reinforced by the urgent need for robust resistance management strategies to address pests that have developed immunity to traditional pesticides.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 4.21 Billion |
| Market Size 2031 | USD 6.78 Billion |
| CAGR 2026-2031 | 8.26% |
| Fastest Growing Segment | Macrobials |
| Largest Market | North America |
Despite this upward trajectory, the industry encounters significant hurdles. Data from the International Biocontrol Manufacturers Association indicates that while the European biocontrol market reached a value of 1.6 billion Euros in 2024 with a growth rate near 10 percent, broader expansion is hindered by a complicated and disjointed regulatory landscape. Inconsistent and protracted approval procedures across various regions often postpone the commercial launch of products, limiting manufacturers' capacity to swiftly bring new innovations to market to satisfy agricultural demands.
Market Driver
Strategic capital allocation and portfolio diversification by leading agrochemical companies serve as primary engines for market growth. Confronted with regulatory restrictions on synthetics and market instability, industry giants are aggressively shifting focus toward biological product lines to ensure stable revenue sources. This strategic realignment is generating concrete operational benefits; for instance, Corteva Agriscience reported in its 'Fourth Quarter 2024 Results' in February 2025 that crop protection volumes rose by 16 percent year-over-year, a surge largely attributed to strong demand for biologicals and novel products in Latin America. Such corporate dedication facilitates the swift commercialization of sophisticated formulations, effectively connecting specialized research with mass-market accessibility.
The extensive implementation of Integrated Pest Management (IPM) strategies further supports this expansion as cultivators look for sustainable methods to manage resistance. Farmers are increasingly utilizing biological inputs alongside conventional treatments, a shift that is altering distribution strategies. According to the '2025 Biologicals Survey' by CropLife in March 2025, 86 percent of agricultural retailers surveyed intend to expand their range of biological products for the coming season. This surging demand is creating significant market value in major agricultural zones; as noted by Revista Cultivar in November 2025, sales of biological pesticides in Brazil reached R$ 4.35 billion for the 2024/25 crop cycle, marking an 18 percent rise over the previous year.
Market Challenge
A disjointed and intricate regulatory landscape remains a major hurdle to the Global Biocontrol Market's growth. In contrast to synthetic agrochemicals, biological products frequently lack specific registration pathways in many regions, compelling manufacturers to adhere to burdensome assessment protocols intended for chemical substances. This lack of alignment leads to excessive data demands and prohibitive compliance costs that fall heavily on small and medium-sized enterprises, which are often the sector's key innovators. Consequently, the financial strain and uncertainty associated with the approval process deter investment in new product development and postpone the release of sustainable pest control solutions.
The consequences of these regulatory inefficiencies are especially evident when comparing different regional markets. The International Biocontrol Manufacturers Association reported in 2024 that European farmers endure waiting periods of up to ten years for biocontrol product approval, whereas competitors in the United States or Brazil generally gain market access within two to three years. This substantial discrepancy limits the supply of effective biological options in areas with sluggish approval systems, thereby constraining the overall market potential and hindering the industry's ability to satisfy the pressing global need for residue-free agricultural inputs.
Market Trends
The rise of RNA-interference (RNAi) based biopesticide technologies marks a pivotal transition toward highly targeted, non-genetic pest management solutions that tackle the escalating problem of chemical resistance. Unlike conventional broad-spectrum inputs, these sprayable formulations employ double-stranded RNA to silence specific genes in target pests without modifying the crop's genome or damaging beneficial insects, thus bypassing the regulatory and public acceptance challenges linked to GMOs. Commercial momentum in this sector is gathering pace as manufacturers advance products from field trials to mass distribution; for example, GreenLight Biosciences announced in March 2025 that it secured $25 million in financing to expand commercial operations for Calantha, the first registered foliar RNA biopesticide developed to combat the Colorado potato beetle.
Simultaneously, the increasing use of biocontrols in seed treatment applications is transforming early-season crop protection by substituting restricted synthetic chemistries, such as neonicotinoids, with microbial inoculants. This approach ensures that beneficial organisms inhabit the rhizosphere immediately after germination, offering systemic protection against soil-borne pathogens and improving resilience to abiotic stress during the crucial establishment stage. This shift toward major row crops is opening up significant market possibilities beyond niche specialty fruits and vegetables; as reported by Evogene in November 2024 regarding the commercial expansion of Yalos, the extension of its bio-inoculant seed treatment into the United States soybean market targets an additional 86 million acres previously dominated by conventional inputs.
Report Scope
In this report, the Global Biocontrol Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Biocontrol Market.
Global Biocontrol Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: